Task: Answer the multiple choice question.
Query: Which drug exhibits a 10.980% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CC1CN(CC(=O)Nc2ccc([N+](=O)[O-])cc2Br)CC(C)O1
b Cc1cc(C)c(NC(=O)/C(=C/c2ccccc2)c2ccccc2)c(C)c1
c Cn1c(=NC(=O)CSCC(=O)N2CCOCC2)sc2ccccc21
Answer: c. Cn1c(=NC(=O)CSCC(=O)N2CCOCC2)sc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(=NC(=O)CSCC(=O)N2CCOCC2)sc2ccccc21
Cn1c(=NC(=O)CSCC(=O)N2CCOCC2)sc2ccccc21
N-(3-methyl-1,3-benzothiazol-2-ylidene)-2-(2-morpholin-4-yl-2-oxoethyl)sulfanylacetamide